A CRISPR–Cas9 strategy targeting centromeric repeats reconfigures up to 11 wheat chromosomes in one generation and yields ...
Japan adopted a law imposing criminal liability for transferring embryos or germ cells with edited genomes for reproductive ...
A Hiroshima University researcher outlines advantages of Japan's new law that prohibits the transfer of genome-edited human ...
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
A Hiroshima University researcher outlines advantages of Japan's new law that prohibits the transfer of genome-edited human ...
A Hiroshima University researcher contends that Japan's newly enacted law regulating human genome-edited embryos and germ ...
IROS, M42’s contract research organisation, and Mammoth Biosciences announced they will conduct the UAE’s first clinical ...
University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that ...
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance laying out its proposed regulatory approach to ...
Capitalize on ready-to-use CRISPR kits & enzymes and drug discovery demand with competitive insights, untapped market analysis, and go-to-market strategies.Dublin, Oct. (GLOBE NEWSWIRE) -- "CRISPR ...
APOC3 in a single administration 76% triglyceride reduction after a single dose in murine disease model NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a ...
Cellectis presented preclinical data supporting HEAL-101, its in vivo base editing product candidate targeting APOC3 for severe hypertriglyceridemia at the Annual Congress of the European Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results